Evidence map›Paper›PMID 27843476›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2016

Applicability of Isolates and Fractions of Plant Extracts in Murine Models in Type II Diabetes: A Systematic Review.

Gabriela Diniz Pinto Coelho, Vanessa Soares Martins, Laura Vieira do Amaral, Rômulo Dias Novaes, Mariáurea Matias Sarandy, Reggiani Vilela Gonçalves

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Mineral Content, Chemical Analysis,Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  3. Mineral Analysis,BioMed research international · 2021
    Article
  4. Frontiers in pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gabriela Diniz Pinto CoelhoDepartment of Medicine and Nursing, Federal University of Viçosa, Viçosa, MG, Brazil.ORCID 0000-0002-0044-3579
Vanessa Soares MartinsDepartment of Medicine and Nursing, Federal University of Viçosa, Viçosa, MG, Brazil.
Laura Vieira do AmaralDepartment of Medicine and Nursing, Federal University of Viçosa, Viçosa, MG, Brazil.
Rômulo Dias NovaesInstitute of Biomedical Science, Department of Structural Biology, Federal University of Alfenas, Alfenas, MG, Brazil.
Mariáurea Matias SarandyDepartment of General Biology, Federal University of Viçosa, Viçosa, MG, Brazil.ORCID 0000-0003-1313-7877
Reggiani Vilela GonçalvesDepartment of Animal Biology, Federal University of Viçosa, MG, Brazil.ORCID 0000-0002-5831-3590
Universidade Federal de Viçosa · BRUniversidade Federal de Alfenas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type II diabetes mellitus is one of the most common public health problems worldwide. Its increasing prevalence in several countries and the difficult metabolic control of individuals with the disease justify studying strategies for primary prevention. The population has sought alternative and cheaper ways to treat the disease, including the use of plants considered medicinal by the population. In this study, we carried out a systematic review on the applicability of isolates and fractions of plant extracts in animal models in type II diabetes. A literature search was performed in MEDLINE/PubMed and Scopus databases. Studies using other experimental animals (horses, rabbits, and monkeys) and humans as well as articles in Chinese, German, and Russian were excluded. We assessed the quality of the studies included by using the criteria described in the ARRIVE guidelines. In general, the animals that received fractions or isolates presented reduced blood glucose levels, normalization of body weight and plasma insulin levels, and reduced total triglycerides and cholesterol. In addition, we observed wide variation among the analyzed parameters, which hindered comparison between the studies found. In further studies, standardized reports and experimental design would help to establish comparable study groups and advance the overall knowledge, thus facilitating translatability from animal data to human clinical conditions.

Identifiers

PMID27843476
PMCPMC5098081
OpenAlexW2538660233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.